Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p82
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 82/312)
Character Range: 15966395–15976302

a solid dose form of topiramate.
C14932              P14932         CN14932          Oxcarbazepine                                                          Seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Compliance with Authority Required procedures - Streamlined Authority Code 14932
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have partial epileptic seizures; or
                                                                                                                           Patient must have primary generalised tonic-clonic seizures; AND
                                                                                                                           The condition must have failed to be controlled satisfactorily by other anti-epileptic drugs.
C14941              P14941         CN14941          Leflunomide                                                            Severe active psoriatic arthritis
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have previously received, and failed to achieve an adequate response to, one or more disease modifying anti-rheumatic drugs including methotrexate; or
                                                                                                                           Patient must be clinically inappropriate for treatment with one or more disease modifying anti-rheumatic drugs including methotrexate; AND
                                                                                                                           The treatment must be initiated by a physician.
C14942              P14942         CN14942          Leflunomide                                                            Severe active rheumatoid arthritis
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have previously received, and failed to achieve an adequate response to, one or more disease modifying anti-rheumatic drugs including methotrexate; or
                                                                                                                           Patient must be clinically inappropriate for treatment with one or more disease modifying anti-rheumatic drugs including methotrexate; AND
                                                                                                                           The treatment must be initiated by a physician.
C14945              P14945         CN14945          Desmopressin                                                           Primary nocturnal enuresis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 14945
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient;
                                                                                                                           Patient must be 6 years of age or older;
                                                                                                                           Patient must be refractory to an enuresis alarm.
C14947              P14947         CN14947          Phenoxymethylpenicillin                                                Recurrent streptococcal infections (including rheumatic fever)
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The treatment must be for prophylaxis.
C14955              P14955         CN14955          Testosterone                                                           Pubertal induction                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Compliance with Authority Required procedures
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient;
                                                                                                                           Patient must be under 18 years of age;
                                                                                                                           Must be treated by a specialist general paediatrician, specialist paediatric endocrinologist, specialist urologist, specialist endocrinologist or a Fellow of the Australasian Chapter of Sexual Health Medicine; or in consultation with one of these specialists; or have an appointment to be assessed by one of these specialists.
                                                                                                                           The name of the specialist must be included in the authority application.
C14956              P14956         CN14956          Testosterone                                                           Constitutional delay of growth or puberty                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of